B
Bernard Charbonnel
Researcher at Centre Hospitalier Universitaire de Nantes
Publications - 5
Citations - 1209
Bernard Charbonnel is an academic researcher from Centre Hospitalier Universitaire de Nantes. The author has contributed to research in topics: Diabetes mellitus & Impaired glucose tolerance. The author has an hindex of 4, co-authored 5 publications receiving 1136 citations.
Papers
More filters
Journal ArticleDOI
Effect of valsartan on the incidence of diabetes and cardiovascular events.
John J.V. McMurray,Rury R. Holman,Steven M. Haffner,M A Bethel,Bjoern Holzhauer,Tsushung Hua,Yuri N. Belenkov,Mitradev Boolell,John B. Buse,Brendan M. Buckley,Antonio Roberto Chacra,Fu-Tien Chiang,Bernard Charbonnel,Chun Chung Chow,Melanie J. Davies,Prakash Deedwania,Peter Diem,Daniel Einhorn,Vivian Fonseca,Gregory R. Fulcher,Zbigniew Gaciong,Sonia Gaztambide,Thomas D. Giles,Edward S. Horton,Hasan Ilkova,Trond Jenssen,Steven E. Kahn,Henry Krum,Markku Laakso,Lawrence A. Leiter,Naomi S. Levitt,Viacheslav Mareev,Felipe Martinez,Chantal Masson,Theodore Mazzone,Eduardo Meaney,Richard W. Nesto,Chang-yu Pan,R. Prager,Sotirios A. Raptis,Guy E.H.M. Rutten,Herbert Sandstroem,Frank Schaper,André Scheen,Ole Schmitz,Isaac Sinay,Vladimír Soška,Steen Stender,Gyula Tamás,Gianni Tognoni,Jaakko Tuomilehto,Alberto S. Villamil,Juraj Vozar,Robert M. Califf +53 more
TL;DR: Among patients with impaired glucose tolerance and cardiovascular disease or risk factors, the use of valsartan for 5 years, along with lifestyle modification, led to a relative reduction of 14% in the incidence of diabetes but did not reduce the rate of cardiovascular events.
Journal ArticleDOI
Effect of nateglinide on the incidence of diabetes and cardiovascular events
Rury R. Holman,Steven M. Haffner,Steven M. Haffner,John J.V. McMurray,M. Angelyn Bethel,M. Angelyn Bethel,Björn Holzhauer,Tsushung A. Hua,Yuri N. Belenkov,Mitradev Boolell,John B. Buse,Brendan M. Buckley,Antonio Roberto Chacra,Fu-Tien Chiang,Bernard Charbonnel,Chun Chung Chow,Melanie J. Davies,Prakash Deedwania,Prakash Deedwania,Peter Diem,Daniel Einhorn,Vivian Fonseca,Gregory R. Fulcher,Zbigniew Gaciong,Sonia Gaztambide,Thomas D. Giles,Edward S. Horton,Hasan Ilkova,Trond Jenssen,Steven E. Kahn,Henry Krum,Markku Laakso,Lawrence A. Leiter,Naomi S. Levitt,Viacheslav Mareev,Felipe Martinez,Chantal Masson,Theodore Mazzone,Eduardo Meaney,Richard W. Nesto,Chang-yu Pan,R. Prager,Sotirios A. Raptis,Guy E.H.M. Rutten,Herbert Sandstroem,Frank Schaper,André Scheen,Ole Schmitz,Isaac Sinay,Vladimír Soška,Steen Stender,Gyula Tamás,Gianni Tognoni,J. Tuomilehto,Alberto S. Villamil,Juraj Vozar,Robert M. Califf +56 more
TL;DR: Among persons with impaired glucose tolerance and established cardiovascular disease or cardiovascular risk factors, assignment to nateglinide for 5 years did not reduce the incidence of diabetes or the coprimary composite cardiovascular outcomes.
Journal ArticleDOI
Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study
Lan Shen,Lan Shen,Bimal R. Shah,Eric M. Reyes,Laine Thomas,Daniel M. Wojdyla,Peter Diem,Lawrence A. Leiter,Bernard Charbonnel,Viacheslav Mareev,Edward S. Horton,Steven M. Haffner,Vladimír Soška,Rury R. Holman,M. Angelyn Bethel,Frank Schaper,Jie Lena Sun,John J.V. McMurray,Robert M. Califf,Henry Krum +19 more
TL;DR: Among people with impaired glucose tolerance and other cardiovascular risk factors and with serial glucose measurements, diuretics and statins were associated with an increased risk of new onset diabetes, whereas the effect of β blockers was non-significant.
Journal ArticleDOI
Lixisenatide plus basal insulin in patients with type 2 diabetes mellitus: a meta-analysis
Bernard Charbonnel,Monica Bertolini,Francisco J. Tinahones,Manuel Puig Domingo,Melanie J. Davies +4 more
TL;DR: Prandial lixisenatide in combination with basal insulin is a suitable option for treatment intensification in patients with T2DM insufficiently controlled by basal insulin, as these agents have complementary effects on PPG and FPG, respectively.
Journal Article
Abstract 14642: Do Diuretics, Beta-Blockers, and Statins Increase the Risk of Diabetes in Patients with Impaired Glucose Tolerance? Insights from the NAVIGATOR Study
Lan Shen,Bimal R. Shah,Eric M. Reyes,Laine Thomas,Peter Diem,Lawrence A. Leiter,Bernard Charbonnel,Viacheslav Mareev,Edward S. Horton,Steven M. Haffner,Vladimír Soška,Rury R. Holman,M. Angelyn Bethel,Frank Schaper,Jie-Lena Sun,John J.V. McMurray,Robert M. Califf,Henry Krum +17 more